McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case
SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Asian Currencies Trade Mixed as Yen Hovers Near 40-Year Low, Dollar Holds Firm on Fed Outlook
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan
Alphabet Replaces Verizon in Dow Jones Industrial Average
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
Gold Prices Fall Below $4,000 as Strong Dollar, Fed Rate Hike Bets Weigh on Bullion 



